Susan E. Morano bought 2,040 shares of Boston Scientific Corp on the open market on Aug. 25, paying $49.22 per share for a total of about $100,410. Open-market purchases matter to many investors because they typically reflect an insider choosing to put personal capital into the stock at the current market price, rather than receiving shares through compensation programs. Morano is listed as an insider but not a senior executive, so her transaction may carry less informational weight than a trade made by the CEO or CFO. Even so, a six-figure purchase is notable for an individual insider and indicates a willingness to increase exposure to the company’s shares at today’s valuation. Over the last 30 days, the only disclosed insider trade in BSX is Morano’s purchase, so there isn’t a clear pattern of repeated buying or selling in the most recent filings. Investors looking for stronger “cluster buying” signals typically watch for multiple insiders buying within a short period; based on the provided activity window, this filing stands alone.